Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.

Yale JF, Bakris G, Cariou B, Yue D, David-Neto E, Xi L, Figueroa K, Wajs E, Usiskin K, Meininger G. Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2013 May; 15(5):463-73.

View in: PubMed

collapse authors with profiles